Treatment of opiate-dependent patients in a general practice;Opioidbehandling av rusmiddelavhengige i en allmennpraksis

Tidsskrift for den Norske Laegeforening

Volumn 127, Issue 13-14, 2007, Pages 1770-1772

  Haarr, Dagfinn ^a   Nessa, John ^b  

^a Sentrum Legesenter   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; NARCOTIC AGENT;

ADULT; ARTICLE; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; INTERVIEW; MALE; MORTALITY; PHYSICIAN ATTITUDE; PROGNOSIS; SOCIOECONOMICS; SUBSTANCE ABUSE;

ADULT; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVIEWS; MALE; METHADONE; NARCOTICS; PHYSICIAN'S ROLE; PROGNOSIS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34447123261     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Waal H, Blix O, Krook A et al. Bruk av metadon i behandlingen av opioidavhengighet. Tidsskr Nor Lægeforen 1999; 119: 237-41.
2. Zanis DA, Woody GE. One-year mortality rates following methadone treatment discharge. Drug Alcohol Depend 1998; 52: 257-60.
3. Hansen MB, Kornør H, Waal H. Bidrag til evaluering av legemiddelassistert rehabilitering i Norge. SKR-rapport nr. 7/2004. Oslo: Seksjon for kliniske rusmiddelproblemer, Universitetet i Oslo, 2004.
4. Scherbaum N, Specka M, Hauptmann G et al. Does maintenance treatment reduce the mortality rate of opioid addicts? Fortschr Neurol Psychiatr 2002; 70: 455-61.
5. Skeie I, Brekke M, Lindbæk M et al. Allmennleger kan ta ansvar for legemiddelassistert rehabilitering. Tidsskr Nor Lægeforen 2007; 127: 296-7.
6. Keen J, Oliver P Rowse G et al. Does methadone maintenance treatment based on the new national guidelines work in a primary care setting? Br J Gen Pract 2003; 53: 461-7.
7. Gibson AE, Doran CM, Bell JR et al. A comparison of bupreonrphine treatment in clinic and primary care settings: a randomised trial. Med J Aust 2003; 179: 38-42.
8. Vanedannende legemidler, forskrivning og forsvarlighet. Rundskriv IK-2755/2001. Oslo: Statens helsetilsyn, 2001.
9. Andersen HT. Regelmessig forskrivning av A- og B-preparater til rusavhengige i allmennpraksis. Tidsskr Nor Lægeforen 2002; 122: 1202-4.
10. Sohlberg C. Stoffmisbrukere bedre-verre enn sitt rykte? Oslo: Miljøetaten, Seksjon for tiltak mot AIDS, 1993.
11. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorfin maintenance versus placebo or methadone maintenance for opoid dependence. I: Cochrane Collaboration. Cochrane Library. Issue 3. Chichester: John Wiley, 2004.
12. Gerada C. Practical aspects of methadone treatment. I: Gerada C, red. RCGP Guide to the management of substance misuse in primary care. London: The Royal College of General Practitioners, 2005.
13. Ravndal E, Lauritzen G. Opioidmisbrukere i metadonassistert rehabilitering ett og to år etter inntak. Tidsskr Nor Lægeforen 2004; 124: 329-31.
14. Kristensen Ø, Espegren O, Åsland R et al. Buprenorfin og metadon til opioidavhengige - en randomisert studie. Tidsskr Nor Lægeforen 2005; 125: 148-51.
15. Kakko J, Svanborg KD, Kreek MJ et al. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, pacebo-controlled trial. Lancet 2003; 361: 662-8.